Brief: MiMedx Q3 Sales USD 81.712 Million Vs. IBES Estimate USD 77.9 Million
30/10/2023 20:01
Oct 30 (Reuters) - MiMedx Q3 net income USD 8.534 million. * Q3 adjusted EBITDA USD 17.619 million * Q3 operating income USD 10.816 million * Q3 EBITDA USD 11.648 million * Q3 gross profit USD 66.922 million
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million